Lucite deal toy celebrating a development and commercialization agreement between Click Therapeutics and Boehringer Ingelheim. The collaboration centers on a prescription digital therapeutic for schizophrenia. (22AKL597)
Lucite deal toy celebrating a development and commercialization agreement between Click Therapeutics and Boehringer Ingelheim. The collaboration centers on a prescription digital therapeutic for schizophrenia. (22AKL597)
Side view of Jupiter-themed deal toy, with spinning plexi, commemorating an agreement focused on a mental health prescription-based digital therapeutic (PDT).